ANPCF 0.13 ANGLE plc
| Range: | 0.132-0.35 | Vol Avg: | 0 | Last Div: | 0 | Changes: | -0.15 |
| Beta: | 0.22 | Cap: | 0.05B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Thu Jan 23 2014 | Empoloyees: | 150 | ||
| CUSIP: | CIK: | ISIN: | GB0034330679 | Country: | GB | ||
| CEO: | Mr. Andrew David William Newland ACA, Meng | Website: | https://angleplc.com | ||||
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow